StockpollyBeta
Get App
Delisting riskPopularity #4,747
SNTI · NASDAQ · Biotechnology

Senti Biosciences (SNTI)

Gene-circuit developer for programmable cell and gene therapies.

$0.3299
After hours+0.01 (+1.95%)
At close$0.3236(+4.39%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Institutions0.81%253.8K shares
1 holder · as of Sep 30, 2025
Insiders2.43%757.8K shares
3 holders · as of Mar 11, 2026
Strategic holders52.96%16.49M shares
4 holders · as of Mar 14, 2025
Other43.80%13.64M shares
remainder

31.14M company shares as of Sep 22, 2026 · institutions as of Sep 30, 2025 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
Celadon Partners SPV 24Strategic10 percent owner
31.39%9.78Mfiled Mar 14, 2025
New Enterprise Associates 15, L.P.Strategic10 percent owner
12.12%3.78Mfiled Mar 12, 2025
Bayer Healthcare LLCStrategic10 percent owner
9.02%2.81Mfiled Mar 12, 2025
Nantahala Capital Management, LLCInstitution
7.13%2.22Mfiled May 15, 2025
Timothy K. LuInsiderdirector, officer: CEO
2.05%639,583filed Mar 11, 2026
8VC GP I, LLCInstitution
0.81%253,755as of Sep 30, 2025
ARK Investment Management LLCInstitution
0.76%237,770filed Sep 10, 2021
Woodline Partners LPInstitution
0.64%200,000filed Feb 11, 2022
JPMorgan Chase & Co.Strategic
0.43%132,500filed Feb 3, 2022
Kanya RajangamInsiderofficer: Pres. & Chief Med. & Dev. Off.
0.35%107,843filed Mar 11, 2026
Donald F. TangInsiderdirector
0.03%10,368filed Dec 10, 2024
Celadon Partners, LLCStrategic
—54.60% of class, as filed—filed Sep 11, 2026
Morgan StanleyInsider
—0.60% of class, as filed—filed Feb 9, 2023
Sculptor Capital Management, Inc.Strategic
—6.49% of class, as filed—filed Feb 11, 2022
T. Rowe Price Associates, Inc.Institution
—8.10% of class, as filed—filed Feb 14, 2023
Omid Farokhzad1Insiderdirector
0.31%25,000 · 71,550filed Jun 10, 2022
Philip J. Lee2Insiderofficer: Chief Technology Officer
0.30%93,642filed Jun 15, 2022
Dynamics Sponsor LLC1Strategicdirector
0.23%71,550filed Jun 10, 2022
Mostafa Ronaghi3Insiderdirector, officer: Chief Executive Officer
0.23%71,550filed May 25, 2021
Curt A. III Herberts2Insiderofficer: Chief Operating Officer
0.15%45,421filed Jun 15, 2022
James J. Collins2Insiderdirector
0.06%17,613filed Jun 15, 2022
David R. Epstein1Insiderdirector
0.04%12,325 · 1,073filed Jun 10, 2022
Deborah Knobelman4Insiderofficer, other: Chief Financial Officer
0.04%13,100filed Feb 2, 2024
Jay T. Flatley3Insiderdirector
0.00%1,073filed May 25, 2021
Dipchand Nishar3Insiderdirector
0.00%1,073filed May 25, 2021
  1. Last filed Jun 10, 2022; leaving the company requires no filing. Not in the bar.
  2. Last filed Jun 15, 2022; leaving the company requires no filing. Not in the bar.
  3. Last filed May 25, 2021; leaving the company requires no filing. Not in the bar.
  4. Last filed Feb 2, 2024; leaving the company requires no filing. Not in the bar.

13F, as of Sep 30, 2025

1 holder · 253.8K shares · 0 new positions · 0 increased · 0 reduced · 0 closed

HolderShares% outstandingChg q/qFiled
8VC GP I, LLC253.8K0.81%0Nov 12, 2025

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Celadon Partners, LLCincl. Celadon Partners SPV 24, CPIF II-7 Limited54.60%25.75M13DSep 11, 2026
Bayer HealthCare LLCincl. Priyal Patel, Sebastian Guth +1 more17.82%6.14M13DApr 16, 2026
New Enterprise Associates 15, L.P.incl. Mohamad H. Makhzoumi, NEA Partners 15, L.P. +4 more12.10%3.78M13DMar 31, 2026
Nantahala Capital Management, LLC8.12%2.22M13GMay 15, 2025

Form 4

Latest trades

No open-market trades in the last 12 months.

House and Senate disclosures

Not reported.